DV
Dividend Vision

CNTX — Context Therapeutics Inc

Context Therapeutics Inc (CNTX)

Total return is -89.7% over the past 4.8 years, 172.7 points behind SPY at 83.0%. Its deepest 1-year drawdown was 86.5%.

CNTX is an equity fund that focuses on a single stock holding rather than a diversified portfolio approach. The fund does not currently offer distributions to shareholders, making it unsuitable for income-focused investors. This structure appeals primarily to those seeking direct exposure to the underlying company's equity performance rather than dividend yield.

CNTX key facts

Asset type
Stock
Asset class
Equity
Inception date
10/20/2021
Last close
$0.52
Market cap
$55,127,508
Average volume
1263848.0
Beta
1.753
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.42